Visit 1 (baseline – on VKA) | Visit 2 (1 month into NOAC) | Visit 3 (2 months into NOAC) | Visit 4 (1 year into NOAC) |
---|---|---|---|
Full medical and drug history obtained, including calculation of aCHADS2 [44], aCHA2DS2VASc [14], HASBLED [45], the Medication Related Complexity Index (MRCI) [46], SAMe-TT2R2 [26], the Charlson index [47] and whether the patient has symptomatic disease or not | Patient reviewed clinically | Patient reviewed clinically | IPQ/BMQ (NOAC)/ACTS instruments administered |
Socio-demographic informationb | Patient self-reported missed doses recorded + pill count | Patient self-reported missed doses recorded + pill count | PTS assessment if DVT patient |
Informed written consent | Another 1 month prescription of NOAC given to patient | Another 1 month prescription of NOAC given to patient | Adherence assessment through GP summary care record, patient self-report and the 8-item Morisky Medication Adherence Scale |
IPQ/BMQ (warfarin)/ACTS instruments administered | Bloods for UEs/FBC | Bloods for UEs/FBC (if not done at visit 2) | |
Patient switched to NOAC (1 month prescription) | IPQ/BMQ (NOAC)/ACTS instruments administered | Patient transferred to GP for on-going prescriptions | |
PTS assessment if DVT patient | PTS assessment if DVT patient | PTS assessment if DVT patient |